Key facts
- This page summarizes Danilo D'Alessandro's Form 4 filing for ClearPoint Neuro, Inc. (CLPT).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 16 Mar 2026, 14:53.
Danilo D'Alessandro - 12 Mar 2026 Form 4 Insider Report for ClearPoint Neuro, Inc. (CLPT)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- CLPT
- Reported as of
- 12 Mar 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 16 Mar 2026, 14:53:33 UTC
- Prior SEC filing
- 13 Mar 2026
- Next SEC filing
- 02 Jul 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Danilo D'Alessandro
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Danilo D'Alessandro filed Form 4 for ClearPoint Neuro, Inc. (CLPT) on 16 Mar 2026.
Change
- Previous filing in this sequence was filed on 13 Mar 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001825163
Primary reporting owner
D'Alessandro Danilo
- Relationship
- Chief Financial Officer
- Address
- C/O CLEARPOINT NEURO, INC., 120 S. SIERRA AVE., SUITE 100, SOLANA BEACH
- Signature
- /s/ Danilo D'Alessandro
- Signature date
- 16 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CLPT
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +32,627
- Change %
- +38%
- Price
- Shares after
- 119,285
- Date
- 12 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
CLPT
transaction
Common Stock
Tax liability
- Transaction value
- Shares
- -16,601
- Change %
- -14%
- Price
- $11.53*
- Shares after
- 102,684
- Date
- 12 Mar 2026
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CLPT
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -32,627
- Change %
- -50%
- Price
- Shares after
- 32,626
- Date
- 12 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 32,627
- Exercise price
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.
Footnote F2
Represents the amount of shares delivered to CLPT to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock.